Clinical Trial Update: Comparing Treatments for Multiple Myeloma [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 trial comparing treatments for multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED